Hospital Raja Permaisuri Bainun
8
1
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults
Role: collaborator
Helmet CPAP vs Facemask CPAP in ACPE (hCPAP vs fCPAP)
Role: lead
Transesophageal Echocardiography To Diagnose Blunt Traumatic Aortic Injury Traumatic Aortic Injury
Role: lead
The Effectiveness of Pharmacist-led Educational Model in Patients With Allergic Rhinitis
Role: collaborator
SUBSUS (SUBglottic Secretion at Ultrasound Score)
Role: lead
Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study
Role: collaborator
Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study
Role: collaborator
Helmet CPAP Versus HFNC in Acute Cardiogenic Pulmonary Edema
Role: lead
All 8 trials loaded